Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.
Dr. Timothy Hresko is a Professor of Orthopedic Surgery at Harvard Medical School and serves as an Orthopedic Surgeon in the Orthopedics and Sports Medicine Department at Boston Children's Hospital. He also holds the position of Director of Spine Research and Quality Improvement in the Department of Orthopedic Surgery. Dr. Hresko received his medical degree from Columbia University, College of Physicians and Surgeons in 1981. He completed his internship at New England Deaconess Hospital in 1982, followed by residency at New England Medical Center in 1987, and a fellowship at Boston Children's Hospital in 1988. He is certified by the American Board of Orthopedic Surgery. His research focuses on orthopedic surgery, particularly spine surgery and pediatric orthopedics. Dr. Hresko's work centers on scoliosis treatment, spinal deformity correction, and outcomes of pediatric spinal fusion surgeries. He has conducted extensive research on surface topography measurements for scoliosis assessment, bracing techniques for adolescent idiopathic scoliosis, and surgical outcomes for various spinal conditions. His recent work explores the biomechanical effects of thoracolumbosacral orthosis design and the relationship between spinal deformity and patient self-image. Dr. Hresko's recent publications demonstrate a strong emphasis on technological advancements in spine surgery, including robotic pedicle screw placement and computer vision algorithms. His work also explores the relationship between socioeconomic factors and surgical outcomes, as well as innovative approaches to non-surgical management of scoliosis. Scoliosis Research Society (SRS) Pediatric Orthopaedic Society of North America (POSNA) American Academy of Orthopaedic Surgeons (AAOS) American Board of Orthopaedic Surgery As Director of Spine Research and Quality Improvement, Dr. Hresko leads initiatives to enhance patient outcomes and optimize care pathways for children with spinal conditions. His work emphasizes evidence-based approaches to pediatric spine care, with particular attention to quality improvement and research translation into clinical practice.
Dr. Ben Clarke is an Associate Professor and Department Head of Special Education and Clinical Sciences at the University of Oregon’s College of Education. His research focuses on mathematical development, assessment systems, and school-based interventions to support student achievement. He has led over 20 federally funded grants totaling ~$55 million, emphasizing early numeracy interventions and multi-tiered instructional models. Clarke’s work bridges theory and practice, with publications on mathematics instruction, assessment, and RTI frameworks. Education: PhD (2002), MA (2001) in School Psychology/Special Education from University of Oregon; BS (1997) in Psychology from Wabash College (Phi Beta Kappa). Research Interests: Mathematics intervention design and efficacy Early numeracy assessment Multi-tiered systems of support (MTSS) Technology in education Equity in mathematics education Publications highlight his focus on intervention fidelity, tiered models, and outcomes for students with learning difficulties. Awards include the AERA Special Education SIG Research Award and recognition for academic excellence. Grants and Advising: Principal Investigator on ~$55M in federal grants; advises graduate students in School Psychology and Special Education. His lab develops evidence-based tools like the KinderTEK iPad program and contributes to national practice guides (e.g., IES RTI for Mathematics). Labs/Teams: Leads research teams focused on early mathematics intervention and MTSS implementation, collaborating with schools and policymakers to scale effective practices.
Milos Popovic is a Professor and Director at the Institute of Biomedical Engineering, University of Toronto, and serves as Senior Scientist and Director of Research at the Toronto Rehabilitation Institute (KITE), University Health Network. He holds the Toronto Rehab Chair in Spinal Cord Injury Research and Neural Engineering and co-leads the Centre for Research in Advanced Neural Implant Applications (CRANIA). His leadership spans academic, clinical, and translational research domains in neuroengineering and rehabilitation. His research focuses on neurorehabilitation, neuroprosthetics, functional electrical stimulation (FES), brain-machine interfaces, and assistive technologies . He develops physiological control systems and therapeutic robotics to restore motor function after spinal cord injury and stroke. His work integrates biomechanics, signal processing, and human-machine interfaces to innovate rehabilitative solutions. Dr. Popovic's recent publications emphasize electrical neuromodulation, FES therapy for motor recovery, deep brain stimulation for cognitive deficits, and wearable/implantable technologies . The articles reflect a strong trend toward closed-loop systems, translational research, and interdisciplinary innovation in neuroengineering and rehabilitation. Swiss National Science Foundation Technology Transfer Award - 1st place (1997) Engineering Medal for Research and Development, Professional Engineers of Ontario (2008) Elected to the College of Fellows, American Institute of Medical and Biological Engineering (2011) 1st Prize and Best Intellectual Property Award, TiEQuest Business Venture Competition (2012) Morris (Mickey) Milner Award for Assistive Technologies (2013) University of Toronto Inventor of the Year Award (2013) University Health Network’s Inventor of the Year Award (2015) Dr. Popovic has secured significant research funding and leads the Neural Engineering and Therapeutics team at KITE. He co-founded MyndTec Inc. and the Canadian National Spinal Cord Injury Conference, demonstrating strong mentorship, innovation, and national impact. He advises graduate students and postdoctoral fellows in biomedical engineering and rehabilitation sciences. He leads the Rehabilitation Engineering Laboratory and the Neural Engineering and Therapeutics Team at KITE, fostering collaboration across engineering, neuroscience, and clinical rehabilitation. His lab develops advanced neurotechnologies with a focus on clinical translation and commercialization.
Ahmed Hassoon is an Assistant Research Professor at the Johns Hopkins Bloomberg School of Public Health, with a primary appointment in the Department of Epidemiology and joint appointments in the Department of Neurology at the School of Medicine and the School of Engineering. He is affiliated with several key research centers, including the Welch Center for Prevention, Epidemiology and Clinical Research, the Center for Diagnostic Excellence, and the Center for Humanitarian Health. MPH, Johns Hopkins Bloomberg School of Public Health, 2014 MD, Baghdad College of Medicine, 2004 Dr. Hassoon’s research is centered on leveraging data science and artificial intelligence to improve healthcare quality and safety, particularly in diagnostic accuracy. His work spans applications in lung cancer, stroke, and emergency medicine, with a strong emphasis on reducing diagnostic errors using frameworks like symptom-disease pair analysis (SPADE). He is deeply engaged in developing AI models that reason across multiple clinical modalities to enhance patient outcomes. His recent publications highlight a strong trend in diagnostic safety, AI-driven interventions, and epidemiological analysis of misdiagnosis harms. Key themes include the validation of computable phenotypes, measurement of diagnostic error burden, and the impact of mental health on acute care diagnostics. Hubert Humphrey Fellowship Award, U.S. Department of State (2010) US President Appreciation Certificate, The White House (2011) Atlas Corps Award (2012) Sommer Scholarship Award (2013) State of Maryland Cigarette Restitution Fund Faculty and Translational Research Awards (2016–2017) Institute for Healthcare Improvement (IHI) Fellowship (2024) Dr. Hassoon is a recipient of the AHRQ K08 Career Development Award focused on improving cancer diagnostic safety at Johns Hopkins Hospital. He co-instructs graduate-level courses in data science and AI with Professor Brian Caffo, contributing to the training of the next generation of public health data scientists. He has not formally advised students listed in the provided texts. His collaborative research spans multiple institutions and has been widely disseminated through policy, news, and social media, indicating significant real-world impact. His work is deeply integrated with the Welch Center and the Center for Diagnostic Excellence, where he contributes to translational research initiatives aimed at improving clinical decision-making and patient safety through innovative data-driven approaches.
FOONG Pin Sym is a Senior Research Fellow at the Saw Swee Hock School of Public Health, National University of Singapore. She leads the Telehealth Core, a research center focused on developing and studying eHealth projects. Her academic background includes a Master's in Human Computer Interaction Design and a PhD in Interactive Media. Her research emphasizes patient-centered technologies, with a focus on chronic disease prevention, caregiver support, and mobile health applications. Her work addresses challenges in healthcare decision-making, end-of-life care, and lifestyle interventions. Notable projects include developing digital tools for diabetes risk communication, caregiver decision support systems, and studies on telehealth during the pandemic. She teaches courses in Human-Computer Interaction, Mobile Interaction Design, and Technology for Older Adults. Her research spans qualitative and quantitative methodologies, including randomized controlled trials and participatory action research. She actively participates in interdisciplinary collaborations across health, technology, and design sectors to improve patient and caregiver outcomes. Education: PhD in Interactive Media, Master's in Human Computer Interaction Design Labs/Teams: Leads the Telehealth Core research team Grants/Projects: SMART-GDM Study, Vita project for dementia care
Sarah Woolf-King is an Assistant Adjunct Professor in the Department of Medicine at the University of California, San Francisco (UCSF), School of Medicine. She is a licensed clinical psychologist (CA PSY28178) whose research bridges psychology and health, with a strong focus on substance use, HIV, and mental health in families affected by congenital heart defects. Her educational background includes a B.S. in Psychology from Arizona State University (2002), an M.S./Ph.D. in Clinical Psychology from Syracuse University (2010), an M.P.H. in Epidemiology from UC Berkeley (2011), a clinical internship in Behavioral Medicine at VA Palo Alto (2010), and a T32 Postdoctoral Fellowship at UCSF’s Center for AIDS Prevention Studies (2013). Dr. Woolf-King’s research centers on two primary areas: (1) the impact of alcohol use on HIV treatment and prevention, particularly among HIV-positive men who have sex with men (MSM) and in East African populations, and (2) the mental health needs of parents of children with critical congenital heart defects (CHD). Her work employs diverse methodologies, including daily data collection, qualitative interviews, randomized trials, and biomarker validation (e.g., PEth). She aims to develop integrated behavioral interventions to improve health outcomes for individuals and families coping with chronic illness. Her recent publications (2023–2025) reflect a consistent focus on alcohol use in the context of HIV, with studies on counseling interventions, digital screening, remote biomarker collection, and behavioral mechanisms. There is also growing attention to mental health in vulnerable populations, including college students and parents of children with genetic or cardiac conditions. Her work is increasingly interdisciplinary, combining psychology, epidemiology, public health, and global health. Scientific Awards: Hellman Fellow, Hellman Fellows Fund (2015–2017) Mentored Research Scientist Development Award (K01), NIH/NIAAA (2013–2018) Loan Repayment Program in Clinical Research, NIH/NIAAA (2011–2016) Ruth L. Kirschstein National Research Service Award (F31), NIH/NIAAA (2008–2010) Mentored Scientist Award in HIV/AIDS, UCSF CFAR (2012–2014) Dr. Woolf-King has served as Principal Investigator on NIH-funded projects, including an R34 grant for a brief ACT intervention for HIV-positive hazardous drinkers and a K01 grant on alcohol and sexual risk behavior. She collaborates extensively with researchers at UCSF and in East Africa, particularly Uganda. While her adjunct title suggests a part-time or non-tenure-track role, she maintains an active research program with significant grant support and a robust publication record. There is no indication of retirement or former staff status.
Laura Robinson is a Senior Lecturer at the School of Psychology , University of Wollongong. She holds a Doctor of Philosophy in Psychology and extensive teaching experience in behavioral sciences, statistics, and applied psychology. Education : PhD in Psychology (2017), Postgraduate Diploma in Psychology (2010), Bachelor of Psychology (2009), and Bachelor of Aviation (2004) Her research focuses on vulnerable populations, particularly women and youth, with expertise in substance use disorders, eating disorders, mental health comorbidity, and health equity. She has published extensively on residential treatment outcomes, continuing care interventions, and stigma reduction in mental healthcare. Recent publications highlight longitudinal analyses of psychological distress, weight stigma, and integrated approaches to substance use and physical health. She supervises PhD students on topics like veterans' mental health, methamphetamine use, and suicide prevention. Laura has received funding from internal and external sources, including grants for stimulant use interventions and health literacy studies. She serves on committees like the Australasian Professional Society for Alcohol and Drugs and contributes to peer-reviewed journals as a reviewer.
Arthur Schafer is a Full Professor in the Department of Philosophy at the University of Manitoba's Faculty of Arts and Founding Director of the Centre for Professional and Applied Ethics. He serves as a National Research Associate of the Canadian Centre for Policy Alternatives and previously held roles as ethics consultant for the Winnipeg Regional Health Authority and Head of the Section of Bio-Medical Ethics in the Faculty of Medicine. His academic credentials include a BLitt in Philosophy from the University of Oxford (1967) and a BA Honours from the University of Manitoba. His distinguished career spans over five decades of ethical scholarship and public engagement. Professor Schafer specializes in professional and applied ethics with intensive focus on bioethics , research ethics , and biomedical conflicts of interest . His work critically examines medical assistance in dying , informed consent , clinical trial ethics , and human rights frameworks , establishing him as a leading voice in Canadian ethical discourse. His philosophical approach bridges theoretical rigor with practical policy applications across multiple professional domains. Analysis of his 13 most recent publications reveals enduring engagement with evolving ethical challenges, particularly the tension between institutional interests and professional integrity. His scholarship demonstrates consistent progression from foundational ethical theory toward contemporary policy applications, with recent work heavily concentrated on medical assistance in dying and pharmaceutical industry influence in healthcare systems. His scientific recognition includes: D. R. Campbell Outreach Award (1984) Olive Beatrice Stanton Award for Excellence in Teaching (1976) Canadian Commonwealth Scholarship (1964) Woodrow Wilson Fellowship (1964) Canada Council Fellow As an active supervisor for Master's and PhD students, Schafer extends his mentorship through ethics consulting for professional associations in Medicine, Engineering, Architecture, Nursing, and Pharmacy. His policy impact is evidenced by service on the Provincial-Territorial Expert Panel on Medical Assistance in Dying and two published reports for the Canadian Centre for Policy Alternatives. His extensive media contributions—including hundreds of CBC appearances and newspaper columns—demonstrate exceptional public scholarship. The Centre for Professional and Applied Ethics, which he founded, functions as a vital interdisciplinary hub connecting academic philosophy with real-world ethical challenges across healthcare, law, and public policy sectors, facilitating ongoing dialogue between scholars, practitioners, and community stakeholders.
Liang Zhao, PhD, MAS, MBA, is a Professor in the Department of Bioengineering and Therapeutic Sciences within the Schools of Pharmacy and Medicine at the University of California, San Francisco (UCSF). Prior to joining UCSF, he served as director of the Division of Quantitative Methods and Modeling (DQMM) in the Office of Research and Standards in the Office of Generic Drugs in the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) from 2015 to 2024. His professional career spans over 19 years with experience at Pharsight, Bristol Myers Squibb (BMS), MedImmune, and the FDA. Dr. Zhao's research focuses on pharmacometrics, drug delivery modeling, and artificial intelligence-based tools that impact drug development and regulatory decision-making. His work encompasses mechanistic models for brain drug delivery, regulatory science modeling and simulation, AI-driven drug discovery and development, drug interactions, biological availability, generic drugs, clinical pharmacology, therapeutic equivalency, computer simulation, and FDA regulatory processes. He has pioneered innovative approaches including model master files for model sharing and model-integrated evidence for generic product development and approval. His research integrates machine learning tools into pharmacometrics to advance drug delivery and bioequivalence assessment methodologies. Dr. Zhao has published over 120 articles and book chapters in prestigious journals. His recent publications demonstrate strong focus on applying advanced modeling techniques, machine learning algorithms, and pharmacometric approaches to solve complex problems in drug development and regulatory science. His work shows consistent innovation in developing quantitative methods to enhance bioequivalence assessment, improve drug product characterization, and support regulatory decision-making for generic drugs. FDA Group Recognition Award, FDA, 2024 Gary Neil Prize for Innovation in Drug Development, American Society for Clinical Pharmacology & Therapeutics (ASCPT), 2023 Commissioner's Special Citation, FDA, 2021 Humanitarian Award, Victims' Rights Foundation, 2020 30+ FDA CDER team and Individual Awards, CDER, FDA, 2011 Academic Award for Executive MBA Class 2009, Judge Business School, University of Cambridge, 2011 Dr. Zhao leads the Zhao Lab at UCSF, which advances drug development and regulatory science through cutting-edge research in pharmacometrics, drug delivery modeling, and artificial intelligence. His work bridges academic research with regulatory applications, demonstrating leadership in translating scientific innovations into practical regulatory frameworks. His experience across industry, regulatory agencies, and academia provides a unique perspective on drug development challenges and opportunities.
Caroline K. Milne, M.D., is Professor (Clinical) of Internal Medicine at the University of Utah School of Medicine, where she also serves as Vice Chair for Education and Program Director of the Internal Medicine Training Program. In addition, she directs the fourth-year sub-internship and leads clinical-skills education for medical students. Education & Training M.D., University of Wisconsin School of Medicine Residency & Chief Residency, Internal Medicine, University of Utah School of Medicine Fellowship in General Medicine / Medical Education Research, University of Pennsylvania M.B.A., Business Administration, University of Utah Fellowship in Executive Leadership in Health Care, Drexel University Research Focus Dr. Milne’s scholarly work centers on medical education research, particularly the assessment and development of clinical skills, evaluation of residency training programs, and policy studies on resident wellness and parental leave. Her investigations employ mixed-methods and multi-institutional survey designs to inform best practices in graduate medical education. Clinically, she practices general internal medicine at the VA Medical Center, integrating bedside teaching with outpatient and inpatient care. This dual role informs her research on optimizing educational experiences within clinical environments and improving systems of care for veterans. Publication Themes Across more than two decades, her peer-reviewed articles reveal consistent themes: evaluating learner performance, refining feedback mechanisms, exploring health-system responses (e.g., during COVID-19), and analyzing policies affecting residents’ well-being. The work bridges education science, health-services research, and quality improvement. Scientific Awards No specific awards are listed in the provided material. Advising & Grant Activity While formal student advisees are not enumerated, Dr. Milne’s roles as Program Director and Director of Clinical Skills imply extensive mentorship of residents and medical students. Grant details are not provided. Laboratories & Teams She collaborates with the Internal Medicine residency leadership team and the School of Medicine’s clinical-skills educators, operating primarily within the University of Utah’s academic medical center and the affiliated VA Medical Center.
Yi Ren is a Lecturer in the Department of History at the University of Pennsylvania's School of Arts & Sciences. His research focuses on modern Chinese history, particularly the dynamics of Chinese Communist propaganda in rural areas during the Mao era (1949–1978). He examines grassroots propagandists like opera actors, rural activists, and child propagandists, highlighting their roles in shaping rural socio-political landscapes. His work integrates archival materials and oral histories to challenge conventional narratives of state control. Education: M.A. in American History (Sino-American Relations), Peking University, 2014 B.A. in History, Sichuan University, 2011 Research Interests: Yi Ren’s work spans modern China, Chinese propaganda mechanisms, and global historical contexts like China’s involvement in WWI. He explores how grassroots agency and localized interactions influenced national policies, emphasizing the interplay between state institutions and rural populations. Publications & Trends: While his early work centered on historical analysis, recent articles (2019–2025) pivot to mental health stigma in China, focusing on caregivers, healthcare providers, and rural communities. Studies emphasize contact-based interventions and systemic challenges in addressing mental health disparities. Awards: None explicitly mentioned in the provided texts. Advising & Grants: No advising students or grants listed. His current project includes translating William H. McNeill’s The Global Condition for Peking University Press (expected 2022). Labs/Teams: No lab affiliations or team details provided.
Dr Virginia Hagger is a Senior Lecturer in Nursing at Deakin University's School of Nursing & Midwifery, part of the Faculty of Health and the Institute for Health Transformation. She specializes in diabetes education, self-management, and psychological wellbeing. Her research focuses on structured education programs, diabetes distress, and workforce development. She holds a PhD and Master of Public Health from Deakin University. Dr Hagger has led numerous national and international studies, including interventions targeting diabetes distress, insulin therapy barriers, and telehealth support. She is affiliated with the Quality and Patient Safety (QPS) Strategic Research Centre and the Australian Centre for Behavioural Research in Diabetes . Awards include the 2019 Alfred Deakin Medal and 2017 Vice-Chancellor's Award for Teaching Excellence. Her teaching spans undergraduate and postgraduate nursing, including units on diabetes pathophysiology and psychosocial contexts. Current doctoral students focus on diabetes distress, social support in Ethiopia, and autonomy in insulin management. Over 30 peer-reviewed articles and grants (e.g., MRFF-funded HypoPAST and LISTEN trials) underscore her contributions to diabetes care innovation and workforce training.
Benjamin Andrew Toll is a Professor in the Department of Public Health Sciences and Psychiatry at the Medical University of South Carolina (MUSC) College of Medicine. He serves as Associate Director of Education and Training for the Hollings Cancer Center, Vice Chair of Research in the Department of Public Health Sciences, Co-Director of the Lung Cancer Screening Program, and Director of the Tobacco Treatment Program at MUSC. Dr. Toll received his BA from Cornell University (1996), MS and PhD from Nova Southeastern University (1999, 2002), and completed his Postdoctoral Fellowship and Internship at Yale University. Dr. Toll is a leading researcher in tobacco cessation, with over 20 years of experience conducting clinical trials focused on developing novel therapeutics for tobacco and nicotine use. His work primarily centers on preventing cancer through tobacco treatment interventions, with particular emphasis on lung cancer screening patients and cancer surgery patients. He has expertise in nicotine replacement therapy, contingency management approaches, gain-framed messaging, and digital health interventions for smoking cessation across diverse populations including older adults and young adults. His recent publications demonstrate a strong focus on implementation science for tobacco treatment programs across various healthcare settings including hospitals, oncology clinics, and primary care. His research examines barriers to treatment, optimal delivery methods (including telehealth and EHR-integrated tools), and effectiveness of various pharmacological and behavioral interventions for smoking cessation. National Cancer Institute funding (R01CA235697, R01CA207229, P50CA196530) National Institute on Drug Abuse funding (P50DA036151, K12DA000167) Continuous funding for over 15 years for tobacco cessation research As a mentor and leader, Dr. Toll oversees the Education and Training program at the Hollings Cancer Center, guiding the development of future cancer researchers. His Tobacco Treatment Program serves as a model for integrating tobacco cessation into comprehensive cancer care, and he has successfully implemented 'opt-out' tobacco treatment programs across multiple hospital systems in South Carolina. Dr. Toll leads a multidisciplinary research team focused on tobacco treatment, including psychologists, pharmacists, physicians, and implementation scientists working together to develop and test innovative approaches to smoking cessation for high-risk populations.
Dr. Michelle J. Johnson is an Associate Professor at the University of Pennsylvania, affiliated with the Perelman School of Medicine in the Department of Physical Medicine and Rehabilitation. She holds secondary appointments in Bioengineering and Mechanical Engineering and Applied Mechanics at the School of Engineering and Applied Science (SEAS). She directs the Rehabilitation Robotic Lab and is actively involved in global health initiatives, particularly in Botswana, focusing on neurorehabilitation for stroke and HIV-related impairments. Bachelor of Science in Mechanical Engineering and Applied Mechanics, University of Pennsylvania PhD in Mechanical Engineering, Stanford University Her research centers on rehabilitation robotics, neurorehabilitation, and the application of technology to address motor and cognitive impairments after brain injury. She is particularly committed to making robotic rehabilitation accessible in low- and middle-income countries. Her work bridges engineering, clinical medicine, and global health equity. The recent publications highlight a strong trend in inclusive, globally applicable rehabilitation robotics. Her work spans clinical trials in Mexico, theoretical frameworks for inclusive design, and comprehensive analyses of global disparities in access to robotic therapy. The focus is on stroke, HIV-related neurological impairments, and technological solutions that are affordable and scalable in resource-limited settings. Dr. Johnson has received significant recognition for her work, including: Fulbright Scholar IEEE Distinguished Lecturer She leads the Rehabilitation Robotic Lab, where she mentors students and develops innovative technologies. She has secured funding and collaborative support for international projects, including data collection in Botswana and the development of a global webinar series (GPMRR) with Elsevier to disseminate knowledge in rehabilitation robotics. Her work includes grant-funded research on characterizing impairment in populations with HIV, stroke, or both, and designing robot-assisted strategies tailored to these needs. Dr. Johnson leads the Rehabilitation Robotic Lab, which focuses on developing and testing robotic systems for neurorehabilitation. The lab emphasizes inclusive design, global applicability, and clinical validation across diverse populations and healthcare settings.
